---
title: "Top 10 HK Stock Losers (6.25)"
description: "ALPHAMAB-B(09966) fell 12.17%, with a trading turnover 46.0 Million HKD, and a year-to-date rose 79.4%. ZHEJIANG SHIBAO(01057) fell 12.15%, with a trading turnover 926.7 Million HKD, and a year-to-dat"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/246037482.md"
published_at: "2025-06-25T08:30:51.000Z"
---

# Top 10 HK Stock Losers (6.25)

> ALPHAMAB-B(09966) fell 12.17%, with a trading turnover 46.0 Million HKD, and a year-to-date rose 79.4%. ZHEJIANG SHIBAO(01057) fell 12.15%, with a trading turnover 926.7 Million HKD, and a year-to-date rose 94.4%. LAEKNA-B(02105) fell 9.14%, with a trading turnover 150.0 Million HKD, and a year-to-date rose 91%.

Hang Seng Index has rose 1.23%, with a year-to-date rose 22%; Hang Seng TECH Index has rose 1.15%, with a year-to-date rose 19.9%.

ALPHAMAB-B(09966) fell 12.17%, with a trading turnover 46.0 Million HKD, and a year-to-date rose 79.4%.

ZHEJIANG SHIBAO(01057) fell 12.15%, with a trading turnover 926.7 Million HKD, and a year-to-date rose 94.4%.

LAEKNA-B(02105) fell 9.14%, with a trading turnover 150.0 Million HKD, and a year-to-date rose 91%.

### Related Stocks

- [09966.HK - ALPHAMAB-B](https://longbridge.com/en/quote/09966.HK.md)
- [01057.HK - ZHEJIANG SHIBAO](https://longbridge.com/en/quote/01057.HK.md)
- [02105.HK - LAEKNA-B](https://longbridge.com/en/quote/02105.HK.md)
- [00340.HK - TONGGUAN GOLD](https://longbridge.com/en/quote/00340.HK.md)
- [02169.HK - CANGGANGRAILWAY](https://longbridge.com/en/quote/02169.HK.md)
- [03933.HK - UNITED LAB](https://longbridge.com/en/quote/03933.HK.md)
- [02367.HK - GIANT BIOGENE](https://longbridge.com/en/quote/02367.HK.md)
- [02489.HK - PERSISTENCEGOLD](https://longbridge.com/en/quote/02489.HK.md)
- [02587.HK - HEALTHYWAY INC](https://longbridge.com/en/quote/02587.HK.md)
- [02633.HK - JACOBSON PHARMA](https://longbridge.com/en/quote/02633.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| HealthyWay Forecasts Return to Profit in 2025 | HealthyWay Forecasts Return to Profit in 2025 | [Link](https://longbridge.com/en/news/275840763.md) |
| Persistence Gold Halts Yantai Output but Presses Ahead With Global Expansion Plans | Persistence Resources Group Ltd has temporarily halted production at its Yantai gold mining subsidiaries due to a local  | [Link](https://longbridge.com/en/news/275468188.md) |
| TUL Roxithromycin Capsules Gain China Consistency Evaluation Approval | The United Laboratories International Holdings Limited (TUL) announced that its subsidiary has received approval from th | [Link](https://longbridge.com/en/news/275299526.md) |
| Tongguan Gold Group Announces Partial Conversion of Convertible Bond, Issues 6 Million New Shares | Tongguan Gold Group Ltd. has announced the partial conversion of its convertible bond by Tongfei Investment Limited, res | [Link](https://longbridge.com/en/news/273958142.md) |
| FDA Approves IND Application for TUL108 Injection from The United Laboratories | The United Laboratories International Holdings Limited announced that its subsidiary, Zhuhai United Laboratories Co., Lt | [Link](https://longbridge.com/en/news/273983115.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.